Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals | Israel National News - Arutz Sheva
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceuticals Reviews | Glassdoor
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceuticals Q4 2016 Earnings
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceutical's Sales Slump 18% - WSJ
TEVA: Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?
Teva enters opioid settlement agreement with US state Rhode Island
In opioid case, NY wants to probe Teva's control of Teva USA
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Outgoing Moderna CMO Lands Seat on Teva Pharmaceuticals Board of Directors | BioSpace
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
News and Media | Teva Pharmaceuticals
Teva sees return to growth after opioid settlement, shares jump | Reuters
FDA approves first generic version of epilepsy drug Sabril from Teva
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
TEVA News Today | Why did Teva Pharmaceutical Industries stock go up today?
News and Media | Teva Pharmaceuticals
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
We see a stable U.S. market place for our generics, says Teva Pharma CEO
